Literature DB >> 25013952

Health-related quality of life in sarcoidosis.

Ingrid H E Korenromp1, Mart A F J van de Laar.   

Abstract

PURPOSE OF REVIEW: The review presents an overview of the scientific publications in the field of health-related quality of life (HRQL) in sarcoidosis. RECENT
FINDINGS: Literature on HRQL in sarcoidosis is limited. HRQL was mainly used as a primary or secondary endpoint in intervention studies. Moreover, most studies have measured HRQL in sarcoidosis by means of the generic questionnaire 36-Item Short-Form Health Survey. Sarcoidosis-specific questionnaires and computer-adapted testing are innovative approaches to the field.
SUMMARY: HRQL as a primary or secondary outcome in sarcoidosis studies is still scarce. In addition to the proper definition of the concept, the mode of measurement of HRQL remains a matter of debate. Because health-economical evaluations require data on gained quality of life, future studies on sarcoidosis should include HRQL as the study endpoint.

Entities:  

Mesh:

Year:  2014        PMID: 25013952     DOI: 10.1097/MCP.0000000000000079

Source DB:  PubMed          Journal:  Curr Opin Pulm Med        ISSN: 1070-5287            Impact factor:   3.155


  3 in total

1.  Cognitive Difficulties and Health-Related Quality of Life in Sarcoidosis: An Analysis of the GRADS Cohort.

Authors:  Karin F Hoth; Jacob Simmering; Anna Croghan; Nabeel Y Hamzeh
Journal:  J Clin Med       Date:  2022-06-22       Impact factor: 4.964

2.  Physical and Psychosocial Concept Domains Related to Health-Related Quality of Life (HRQL) in 50 Girls and 52 Boys Between 5 and 18 Years Old in Poland Using the Parent-Reported 50-Item Child Health Questionnaire (CHQ-PF50).

Authors:  Lechosław Paweł Chmielik; Grażyna Mielnik-Niedzielska; Anna Kasprzyk; Tomasz Stankiewicz; Artur Niedzielski
Journal:  Med Sci Monit       Date:  2022-06-09

3.  FeV1 and BMI influence King's Sarcoidosis Questionnaire score in sarcoidosis patients.

Authors:  Björn Christian Frye; Laura Potasso; Erik Farin-Glattacker; Surrinder Birring; Joachim Müller-Quernheim; Jonas Christian Schupp
Journal:  BMC Pulm Med       Date:  2021-12-03       Impact factor: 3.317

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.